UiPath (NYSE:PATH) Given New $15.00 Price Target at BMO Capital Markets

UiPath (NYSE:PATH) had its price objective hoisted by equities researchers at BMO Capital Markets from $14.00 to $15.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “market perform” rating on the healthcare company’s stock. BMO Capital Markets’ price objective suggests a potential upside of 17.74% from the stock’s current price.

Other research analysts also recently issued reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Thursday, May 30th. Barclays dropped their price target on UiPath from $16.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Monday, August 19th. Wells Fargo & Company dropped their price target on UiPath from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Friday, June 21st. Canaccord Genuity Group dropped their price target on UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a research note on Friday, May 31st. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, UiPath presently has a consensus rating of “Hold” and an average price target of $18.12.

UiPath Price Performance

Shares of UiPath stock opened at $12.74 on Friday. UiPath has a one year low of $10.37 and a one year high of $27.87. The stock’s 50-day moving average is $12.22 and its 200 day moving average is $16.80. The firm has a market cap of $7.30 billion, a price-to-earnings ratio of -79.63 and a beta of 0.87.

UiPath (NYSE:PATH) last announced its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same quarter in the prior year, the company earned ($0.09) EPS. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. On average, sell-side analysts expect that UiPath will post -0.22 EPS for the current fiscal year.

Institutional Trading of UiPath

Institutional investors and hedge funds have recently modified their holdings of the stock. Sanctuary Advisors LLC purchased a new stake in shares of UiPath during the second quarter valued at approximately $155,000. Advisory Alpha LLC purchased a new stake in shares of UiPath during the second quarter valued at approximately $131,000. Capital Impact Advisors LLC increased its position in shares of UiPath by 162.9% during the second quarter. Capital Impact Advisors LLC now owns 36,400 shares of the healthcare company’s stock valued at $462,000 after acquiring an additional 22,553 shares during the last quarter. Sunbelt Securities Inc. increased its position in shares of UiPath by 15.4% during the second quarter. Sunbelt Securities Inc. now owns 20,970 shares of the healthcare company’s stock valued at $266,000 after acquiring an additional 2,792 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of UiPath by 2,495.4% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 682,078 shares of the healthcare company’s stock valued at $8,649,000 after acquiring an additional 655,798 shares during the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.